Tao Jiang

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Fengcai Zhu, Yu-Hua Li, Xu-Hua Guan et al. · The Lancet · 2020 · 1.4K citations · Full text

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li et al. · The Lancet · 2020 · 1.3K citations · Full text

Etiological and epidemiological features of acute respiratory infections in China

Zhongjie Li, Qing‐Bin Lu, Xiang Ren et al. · Nature Communications · 2021 · 468 citations · Full text

Asthma, Nationwide Prospective Surveillance, Respiratory Virus Immunity +16

A Broadly Flavivirus Cross-Neutralizing Monoclonal Antibody that Recognizes a Novel Epitope within the Fusion Loop of E Protein

Yong‐Qiang Deng, Jianxin Dai, Guanghui Ji et al. · PLoS ONE · 2011 · 177 citations · Full text

Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions

Guangchuan Wang, Ruiyuan Cao, Rong Chen et al. · Proceedings of the National Academy of Sciences · 2013 · 158 citations · Full text

Peptide-induced Virus Self-biomineralization, Engineering, Biomimetic Materials +19